Want to join the conversation?
$PCAR's average earning assets in 2016 are expected to be comparable to the record levels achieved in 2015. Capital investments in 2016 are expected to be $325-375MM, and R&D is expected to be $240-270MM focused on enhanced aftermarket support, manufacturing facilities and new product development.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.